Department of Biochemistry, Microbiology and Immunology,1 Centre for Research in Biopharmaceuticals and Biotechnology,2 Department of Biology, University of Ottawa, Ottawa, Ontario, Canada K1H 8M5,3 Department of Biochemistry and Molecular Biology, Southern Illinois University, Carbondale, Illinois 62901-44134
Received 25 November 2003/ Accepted 27 January 2004
| ABSTRACT |
|---|
|
|
|---|
-7 helix of MinD. | INTRODUCTION |
|---|
|
|
|---|
Size exclusion chromatography, as well as limited proteolytic analyses, indicated that E. coli MinC (MinCEc) exists as a dimer (30). The MinCEc monomer consists of two separate domains joined by a flexible linker; the N-terminal domain comprises amino acid residues 1 to 99, and the C-terminal domain includes residues 125 to 231 (11). The N terminus of MinCEc interacts with FtsZEc (10), while the C terminus has been implicated in self-interaction and interaction with MinDEc (11). It has been proposed that the interaction of MinCEc with MinDEc brings the N terminus of MinCEc close to its target, FtsZEc (15).
The crystal structure of Thermotoga maritima MinC (MinCTm) indicated that it comprises four molecules arranged as two dimers (4). The N- and C-terminal domains of MinCTm are bound by a flexible linker, which is hypervariable between species (4). The N-terminal domain of each monomer contains two
-helices and five ß-strands, and the C-terminal domain consists of a right-handed ß-helix, which resembles a triangular barrel with three surfaces, A, B, and, C (4). The dimerization interface for MinCTm was found to be located on the hydrophobic A surface, although no specific amino acid residues were implicated in this function (4). The MinC residues implicated in the MinC-MinD interaction have not been identified.
In a current E. coli model explaining how the Min proteins act to determine the septation site, it is proposed that MinD dimerizes in the cytoplasm in the presence of ATP and then binds to a MinC dimer (12, 13). This MinCDEc complex then interacts with the cell membrane (12, 21, 31). The subsequent binding of MinEEc to the MinCDEc complex causes the displacement of MinCEc and stimulates the ATPase activity of MinDEc (13, 19, 21). As a result of ATP hydrolysis, MinDEc and MinEEc are released from the membrane. Through membrane-associated coiled structures, MinDEc oscillates from one end of the cell to the other and at the same time recruits MinCEc away from the cell center, allowing accumulation of FtsZ in this region (19, 21, 28). Gonococcal Min proteins also exhibit dynamic behavior in both rod-shaped and round E. coli cells, which divide in alternating perpendicular planes as N. gonorrhoeae does (24). Since the MinCEc and N. gonorrhoeae MinC (MinCNg) proteins play a critical role in the functioning of the min system in their hosts and since the C-terminal domains of these proteins are highly conserved, we were interested in establishing what role could be attributed to specific completely conserved residues in the function of MinCNg or MinCEc.
Alignment of MinC sequences from 36 different bacterial species indicated that while the MinC C terminus is highly conserved, only five residues (four glycines and one arginine) are identical. Glycine is unique among the amino acids due to its small size, the enhanced backbone flexibility that it confers (1), and its involvement in protein stability (16) or in protein-protein interactions (2). For these reasons, we investigated the functional roles of the conserved glycines in the C terminus of MinCNg and MinCEc by amino acid substitution using site-directed mutagenesis.
In this study, we found that the completely conserved C-terminal glycines are essential for maintaining MinC functionality as a cell division inhibitor and for the interaction of MinC with other Min proteins. On the basis of existing crystal structures of the MinC and MinD proteins and taking into account which MinC glycine residues should be surface exposed, we propose a specific interaction between residues on the
-7 helix of MinD and the B-C surface junction of MinC.
| MATERIALS AND METHODS |
|---|
|
|
|---|
was used for cloning purposes. E. coli PB103 (wild type) and E. coli DR105 (minC) were used for expression and complementation studies, respectively. E. coli C41(DE3) was used as an expression strain for purification of six-His-tagged MinCNg. E. coli cells were grown at 37°C for 6 to 8 h in Luria-Bertani broth (Difco) supplemented with 100 µg of ampicillin per ml and 40 µM isopropyl-ß-D-thiogalactopyranoside (IPTG), when required. Saccharomyces cerevisiae strain SFY526 (Clontech) was used in yeast two-hybrid assays to examine protein-protein interactions. Yeast was grown at 30°C on yeast extract-peptone-adenine-dextrose medium or on the appropriate synthetic dropout media to select for transformants, as described in the Clontech yeast two-hybrid manual.
|
|
Similarly, wild-type minCNg was mutagenized in pSR2 (Table 1) by IPCR. Mutated minCNg genes with G138D, G157D, G164S, G174E, and E144I substitutions were created by using primer pairs minCG138-1 plus minCG138-2, minCG157-1 plus minCG157-2, minCG164-1 plus minCG164-2, minCG174-1 plus minCG174-2, and minCE144-1 plus minCE144-2 (Table 2), generating plasmids pVG4, pVG6, pVG8, pVG10, and pPF1 (Table 1), respectively. Plasmids containing mutant minC genes were screened for mutations by PCR amplification of minCNg with primers min10 and min29 (Table 2) and by PCR amplification of minCEc with primers EcminC-up and EcminC-down (Table 2). Purified amplicons were screened for mutations by digestion with appropriate enzymes since each site-directed mutation introduced a novel restriction site in the mutated gene that was not present in wild-type minCEc or minCNg (Table 2). It was thus possible to screen for minC mutants by examining the restriction endonuclease digestion patterns of plasmid-encoded minC genes from transformants and comparing them with the pattern of the wild-type minC gene. All mutant minC genes were sequenced to confirm point mutations, frame conservation, and gene integrity at the Biotechnology Research Institute, University of Ottawa.
Construction of recombinant MinCCh containing the N terminus of MinCEc and the C terminus of MinCNg. Since no interactions of gonococcal MinC with itself or with MinDNg could be detected by using yeast two-hybrid methods, a chimeric MinC protein (MinCCh) was constructed to determine whether combined N- and C-terminal domains from MinCEc and MinCNg could restore these interactions. Plasmid pEGFP (Clontech) was used to make these constructs since it had suitable restriction sites needed for sequential cloning; however, the gfp gene was deleted, leaving only the chimeric minC gene (minCCh) cloned in the vector. The chimeric protein, MinCCh, comprised the N-terminal domain of MinCEc and the flexible linker and C-terminal domain of MinCNg. A 314-bp fragment which encoded amino acids 1 to 99 of MinCEc was PCR amplified with primers NEc-up and NEc-down, which contained PstI and SpeI restriction sites at their 5' and 3' ends, respectively (Table 2). This fragment replaced a PstI-SpeI fragment in pEGFP, deleting gfp and generating pSR23 (Table 1). A 425-bp fragment encoding amino acids 103 to 237 of MinCNg was PCR amplified with primers CNg-up and CNg-down containing SpeI and ApaI restriction sites at their 5' and 3' ends, respectively (Table 2). This partial minCNg fragment was cloned into pSR23 that had previously been digested with SpeI and ApaI, and pSR24 was generated with a chimeric minC gene encoding MinCCh (Table 1). minCCh was confirmed to be in frame by DNA sequencing at the Biotechnology Research Institute, University of Ottawa.
Morphological studies of E. coli transformants to determine MinC functionality. To determine whether mutations in conserved glycine residues of MinC allowed the protein to retain its functionality, E. coli PB103 was transformed with plasmids containing each point mutation in minCEc (pSR32G135, pSR32G154, pSR32G161, pSR32G171, and pSR32P141), as well as with plasmids containing point mutations in gonococcal minC (pVG4, pVG6, pVG8, pVG10, and pPF1). Plasmids pSR2 (wild-type minCNg) and pSR32 (wild-type minCEc) were used as positive controls, and pUC18 was used as a negative control. Induction of filamentation due to the inability to form proper septa at the middle of the cell in E. coli has been used previously as an indicator of MinC functionality (5, 8, 12, 23). Similarly, to determine whether MinCCh retains functionality as a cell division inhibitor, E. coli PB103 was transformed with plasmid pSR24 encoding MinCCh. As no significant morphological differences were observed in cells with and without IPTG induction, all expression assays were conducted without induction and were repeated at least three times.
E. coli filamentation, defined as production of cells that were at least fourfold longer than wild-type rods (5), was assessed by both phase-contrast microscopy and flow cytometry. For phase-contrast microscopy, samples from each transformant were fixed to 0.1% polylysine-coated coverslips by using the protocol of Ramirez-Arcos et al. (23). Cells were visualized at a magnification of x100 with oil immersion by phase-contrast microscopy by using a Zeiss Axioskop microscope. At least 10 microscope fields were examined for each transformant, and each field contained a minimum of 100 cells, which were analyzed to determine the percentage of filaments or normal-size short rods. Photographs were obtained with a Sony Power HAD 3CCD color video camera and Northern Eclipse software, version 6.0. Flow cytometry was used to determine the percentages of filamentous cells (length, >10 µm) and wild-type rods (length, 2 to 5 µm) in the whole population of E. coli cells. Cells were suspended in 1 ml of filter-sterilized phosphate-buffered saline to reduce the presence of background particles. Transformants were analyzed with a Beckman Coulter Epics XL-MCL flow cytometer at a voltage and gain of 50 V and 1.0, respectively, for side scatter and at a voltage and gain of 127 or 459 V and 1.0, respectively, for forward scatter. The event retrieval time was set to 300 s, and a maximum of 100,000 events were examined. Data retrieval and analysis were performed by using EXPO32 ADC XL 4 Color software and EXPO32 v.1.2 software, respectively. Gate A was created around wild-type rods by using PB103 transformed with pUC18 as a negative control. Gate B was created around filamentous cells by using PB103 transformed with pSR2 and pSR32 expressing MinCNg and MinCEc, respectively, as positive controls. The percentage of cells within each gate was calculated by determining the percentage of total gated cells within each gate and excluding background noise and particulate matter. A Students t test was used to determine significant differences in percentages of filamentation between wild-type and mutant proteins.
E. coli DR105 (minC) was used for complementation studies with gonococcal MinC having mutations at the conserved glycines, using previously described protocols (23).
Yeast two-hybrid assays. Wild-type minCNg and minCEc, as well as minCCh, were PCR amplified individually by using primers incorporating EcoRI and BamHI restriction sites at the 5' and 3' ends, respectively (Table 2). Each gene was ligated in frame with the GAL4 DNA binding domain (BD) and the GAL4 activation domain (AD) of pGBT9 and pGAD424 (Clontech), respectively. The plasmids containing wild-type minCNg and minCEc were pGADminC (AD-MinCNg), pGBT9minC (BD-MinCNg), pSRAD-C (AD-MinCEc), and pSRBD-C (BD-MinCEc) (Table 1). The plasmids containing mutated minCEc were pSRAD-G135 (AD-MinCEc G135D), pSRBD-G135 (BD-MinCEc G135D), pSRAD-G154 (AD-MinCEc G154D), pSRBD-G154 (BD-MinCEc G154D), pSRAD-G161 (AD-MinCEc G161S), pSRBD-G161 (BD-MinCEc G161S), pHDAD-G171 (AD-MinCEc G171E), pHDBD-G171 (BD-MinCEc G171E), pSRAD-P141 (AD-MinCEc P141A), and pSRBD-P141 (AD-MinCEc P141A) (Table 1). Wild-type MinCEc interacted with MinDEc whether it was fused to the GAL4 DNA AD or the GAL4 DNA BD; however, the interaction was much stronger when MinCEc was fused to the GAL4 DNA BD. Hence, wild-type and mutant MinCEc fusions to this domain were used to examine their interactions with MinDEc, which was fused to the GAL4 DNA AD. The plasmids containing minCCh were pSRAD-Ch (AD-MinCCh) and pSRBD-Ch (BD-MinCCh) (Table 1). MinCCh interacted with MinDNg only when it was fused to the DNA BD of GAL4. Therefore, we constructed plasmids encoding mutant MinCCh proteins that were fused only to this domain. The gonococcal minC fragment encoding the C terminus of MinCCh in pSRBD-Ch (BD-MinCCh) was replaced with PCR fragments encoding the MinCNg G138D, G157D, G164S, G174E, and E144I mutants. These fragments were amplified from plasmids pVG4, pVG6, pVG8, pVG10, and pPF1 by using primers CNg-up and min29, containing SpeI and BamHI restriction sites at their 5' and 3' ends, respectively (Table 2). After SpeI and BamHI digestion of these fragments, they were ligated to a DNA fragment corresponding to pSRBD-Ch that had previously been digested with the same enzymes that excluded the region encoding the C terminus of wild-type MinCNg in this plasmid, and plasmids pSRBD-ChG135, pSRBD-ChG154, pSRBD-ChG161, pSRBD-ChG171, and pPF2 were generated (Table 1). These plasmids were transformed into E. coli PB103 for overexpression studies of the MinCCh mutant proteins. Filamentation was evaluated by phase-contrast microscopy. Plasmids pGADminD (AD-MinDNg), pGBT9minD (BD-MinDNg), pSRAD-D (AD-MinDEc), and pSRBD-D (BD-MinDEc) had been constructed previously in our laboratory (29) (Table 1).
All plasmids were transformed into S. cerevisiae SFY526 singly as negative controls or in pairs to test for protein-protein interactions by using the lithium acetate method (Clontech yeast two-hybrid manual). Yeast transformants were assayed for ß-galactosidase activity by using the colony lift method with 5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside (X-Gal) as a substrate and by liquid assays with o-nitrophenyl-D-galactopyranoside as a substrate as described in the Clontech yeast two-hybrid manual. Both colony lift and liquid assays were performed in triplicate at least twice for each interaction. Standard deviations were determined for the averages of the ß-galactosidase activities. A Students t test was used to determine significant differences between ß-galactosidase activities representing the strength of protein-protein interactions.
Protein analysis and Western blotting of bacterial and yeast extracts. Protein extracts from E. coli PB103 expressing MinCNg, MinCEc, and MinCCh proteins with point mutations were prepared as described previously (23). Protein extracts from S. cerevisiae expressing mutant MinCEc and MinCCh fused to the GAL4 AD and the GAL4 BD were prepared by using the method described by Horváth and Riezman (9). Cells were grown to optical density at 600 nm of 1.5, harvested, washed in sterile ddH2O, and resuspended in 100 µl of sample buffer (0.06 M Tris-HCl [pH 6.8], 10% glycerol, 2% sodium dodecyl sulfate, 0.0025% bromophenol blue). Samples were boiled for 5 min and then centrifuged at 14,000 rpm for 5 min (Sorvall MC 12V centrifuge) and the supernatants were designated the total-protein fractions. Bacterial and yeast protein fractions were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and protein concentrations were standardized prior to membrane transfer by densitometry as described previously (23). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis-resolved proteins were transferred to Immobilon-P membranes (Millipore Corporation), and Western blotting was performed by using methods described previously (23). The membranes were incubated with 1:100 anti-MinCNg antiserum overnight at 4°C. Differences in protein expression levels were calculated by densitometry.
Purification of His6-MinCNg and circular dichroism (CD) analysis. To purify wild-type and mutant MinCNg, the coding region of minCNg was PCR amplified with primers HLC2 and HLC3, which incorporated NdeI and HindIII restriction sites at the 5' and 3' ends, respectively (Table 2), by using pSR2 (wild-type MinCNg), pVG4 (MinCNg G138D), pVG6 (MinCNg G157D), pVG8 (MinCNg G164S), and pVG10 (MinCNg G174E) as templates. The genes were fused in frame to the C-terminal His6 tag of pET30a (Novagen), generating pHLCC, pETminCG138, pETminCG157, pETminCG164, and pETminCG174, respectively (Table 1). The fusions were confirmed to be in frame by DNA sequencing. Log-phase cultures (500 ml) of E. coli C41(DE3) carrying these plasmids were induced with 0.4 mM IPTG for 0.5 h at 37°C with shaking at 250 rpm. Protein purification was performed as previously described (29), with a few modifications: proteins were washed with a buffer containing 30 mM imidazole, 0.5 M NaCl, and 20 mM Tris-HCl (pH 7.9) and were eluted with the same buffer containing 250 mM imidazole, as described by Novagen. The protein concentration was determined by the Bradford method by using the Bio-Rad protein assay dye reagent.
CD spectroscopy was performed with a model 62DS CD spectrometer (AVIV Instruments, Inc., Lakewood, N.J.) with 1-mm-path-length quartz cell. The sample temperature was maintained at 20 ± 0.2°C. Far-UV CD spectra were recorded for both the wild-type protein and the mutants at protein concentrations between 0.1 and 0.2 mg/ml in 10 mM ammonium bicarbonate buffer (pH 8.0). All CD experiments were repeated three times to ensure spectral reproducibility. Following baseline subtraction, the CD spectra were normalized based on protein concentrations and were expressed in molar ellipticity per mean residue.
Protein alignment and modeling. MinC sequences from 36 different prokaryotic microorganisms were obtained from the National Center for Biotechnology Information website (http://www.ncbi.nlm.nih.gov/). These sequences were aligned by using Clustal W software (http://searchlauncher.bcm.tmc.edu/multi-align/multi-align.html).
Molecular modeling was performed by using SWISS-MODEL (http://www.expasy.org/swissmod/SWISS-MODEL.html). Briefly, we used MinCTm (PDB 1HF2) (4) and Pyrococcus furiosus MinD (MinDPf) (PDB 1G3R) (8) solved structures as templates for molecular modeling of a MinCTm-MinDPf complex. MinDPf has been previously modeled as a dimer by using the dimeric structure of the nitrogenase iron protein NifH (PDB 1N2C) (12, 21). Using this method, we superimposed MinDPf onto NifH to obtain a MinDPf dimer. We positioned this MinDPf dimer with the C terminus of a MinCTm monomer in a situation where a MinCTm-MinDPf interaction could occur between the MinDPf
-7 helix and the B-C surface junction of MinCTm. We calculated the overall exposure (fraction of solvent-accessible surface area) of the conserved glycine residues (G111, G129, G136, and G146) of MinCTm using the computer program VADAR (33). We also analyzed the structural flexibility that the conserved glycines conferred to MinCTm by measuring their specific temperature factors or B values (B factors) using Swiss-PDB (http://au.expasy.org/spdbv/). The B factors are linearly related to the mean square displacement of an atom and give an indication of atomic flexibility in the crystalline state of a protein.
| RESULTS |
|---|
|
|
|---|
|
The functionalities of the different glycine mutants were determined by their abilities to inhibit cell division, as observed by filamentation, when they were overexpressed in wild-type E. coli PB103 (Table 1). Induction of filamentation in E. coli upon overexpression of MinC has often been used as an indicator of MinC functionality (5, 8, 12, 23). After transformation of E. coli PB103 with plasmids encoding the MinCNg or MinCEc mutants, phase-contrast microscopy and flow cytometry were used to assess the presence and extent of filamentation compared to the filamentation of wild-type rod-shaped cells.
In the analysis of MinC overexpression in E. coli by phase-contrast microscopy, at least 1,000 cells from random microscopic fields were counted. Approximately 90% of the E. coli cells overexpressing wild-type MinCNg from pSR2 (which encodes MinCNg cloned into pUC18) were filamentous, as were cells overexpressing the neutral MinCNg mutant E144I (Table 3). Most (
99%) of the E. coli cells carrying pUC18, which served as a negative control, had a typical wild-type, short-rod morphology, indicating that normal cell division occurred. Mutant MinCNg proteins with mutations at each of the individual conserved glycines did not result in significant filamentation upon overexpression in E. coli, indicating that each mutant was not able to function as a cell division inhibitor (Table 3). The percentage of filamentation for the MinCNg glycine mutants varied from 0.07 ± 0.03 to 1.28 ± 0.38% (Table 3). Overexpression of the four glycine mutants of MinCEc also failed to produce filamentation in E. coli PB103, indicating that the mutations produced nonfunctional MinCEc proteins. The percentage of filamentation for these mutants varied between 0.75 ± 0.08 and 3.12 ± 0.39%, (Table 3). By contrast, overexpression of the MinCEc P141A mutant protein resulted in a filamentous phenotype similar to that of wild-type MinCEc, providing further evidence that the P141A mutation was neutral in affecting functionality (Table 3). Thus, the four conserved glycine residues in MinCEc or MinCNg are implicated in the function of MinC as a cell division inhibitor.
|
|
Although the abrogated function of MinC glycine mutants is consistent with a critical role for the glycine residues, it was possible that the mutants exhibited altered functions due to low levels of MinC expression. We determined the levels of expression of the wild-type and mutant MinCEc and MinCNg proteins in E. coli PB103 by Western blotting using antiserum to MinCNg, which cross-reacted with MinCEc (23). Densitometric analysis of MinC bands showed that wild-type MinCEc and MinCEc mutants G135D, G154D, and G161S had similar expression levels, which overall were
3.5-fold greater (Fig. 3A, lanes 2 to 5) than the expression levels of native MinCEc (Fig. 3A, lane 1). MinCEc mutants G171E and P141A had 2.5- and 3.0-fold-greater protein levels, respectively (Fig. 3A, lanes 6 and 7) than cells with native MinCEc (Fig. 3A, lane 1). Our results demonstrate that between 3.0-fold (MinCEc P141A) and 3.5-fold (wild-type MinCEc) overexpression of MinCEc is enough to cause filamentation in wild-type E. coli PB103 (Table 3). Since the levels of overexpression in MinCEc mutants G135D (Fig. 3A, lane 2), G154D (Fig. 3A, lane 3), and G161S (Fig. 3A, lane 4) were comparable to levels observed when the wild-type protein was overexpressed, the lost functionality was not due to altered levels of protein expression. It is still possible that the decreased expression of the MinCEc G171E mutant relative to the level of expression of wild-type MinCEc resulted in its inability to induce filamentation in E. coli PB103.
|
Specific MinCEc glycine mutants have altered interactions with themselves or MinDEc. Interactions of MinCEc with itself and with MinDEc have been determined previously by using yeast two-hybrid methods (11). This method was therefore used to analyze the self-interactions of the four MinCEc glycine mutants, as well as their interactions with MinDEc (Table 3). MinCEc mutant G161S did not have the ability to self-interact (Fig. 4), in contrast to MinCEc mutants G135D, G154D, G171E, and P141A, which were capable of homodimer formation (although the self-interaction of the G171E mutant was significantly decreased compared to that of wild-type MinCEc[Fig. 4]). However, unlike MinCEc G161S, the MinCEc G135D, G154D, and G171E mutants were not able to interact with MinDEc, indicating that MinC homodimerization can be preserved while MinC-MinD interactions are selectively disrupted. It should be noted that the strength of the interaction of MinCEc G161S with MinDEc was significantly less than the strength of the wild-type interaction (Fig. 4). The neutral P141A mutation did not significantly alter the MinCEc-MinDEc interaction (Fig. 4).
|
|
It has been demonstrated previously that the N-terminal domain of MinCEc by itself does not interact with either MinCEc or MinDEc (11). Therefore, the MinCCh protein should impart MinCNg functionality since the interactions with itself and with MinD should be mediated by the C terminus. Plasmid pSR24, which encodes MinCCh, was constructed to contain the first 99 N-terminal residues of MinCEc and the flexible linker and C terminus of MinCNg (residues 103 to 237). Chimeric MinC mutants containing substitutions at the conserved glycines (G135, G154, G161, and G171) and at the nonconserved E141 residue were constructed. The residues of the C terminus of MinCCh were renumbered to correspond to the MinCEc numbering. As expected, overexpression of the wild-type MinCCh protein and overexpression of the neutral E141I mutant protein were able to induce filamentation in E. coli PB103 (Table 3). By contrast, overexpression of the G135D, G154D, G161S, and G171E chimeric mutants indicated that they were nonfunctional since they could not induce filamentation (Table 3). Western blotting revealed that the levels of expression of chimeric proteins in E. coli were similar to the level of expression of the wild-type MinCNg (data not shown).
Despite the inability of wild-type MinCCh to self-interact in yeast two-hybrid assays, this protein interacted with MinDNg (Fig. 5 and Table 3), and therefore interactions between MinCCh mutants and MinDNg were tested. As observed for the analogous MinCEc mutants, MinCCh G135D, G154D, and G171E mutants were not able to interact with MinDNg, in contrast to the MinCCh G161S mutant, which was able to interact with MinDNg (Fig. 5 and Table 3). As expected, the neutral E141I mutation did not significantly affect the interaction of MinCCh with MinDNg (Fig. 5 and Table 3). Western blotting was again ineffective in detecting the MinCCh mutants from yeast extracts with anti-MinCNg antiserum. These results show that the same three glycine residues that are important for an E. coli MinC-MinD interaction are implicated in N. gonorrhoeae MinC-MinD interactions as well.
MinC glycine residues residing in the B-C surface junction of the MinC C terminus are involved in the MinC-MinD interaction. We positioned the conserved glycines in the C terminus of MinCTm (G111, G129, G136, and G146) using the crystal structure of this protein (4). Due to the high level of conservation of MinC C-terminal residues, it is likely that the homologous glycines of MinCEc (G135, G154, G161, and G171) and MinCNg (G138, G157, G164, and G174) are located at similar positions. The G111 and G129 glycines of MinCTm are in the first and second turns, respectively, of the ß-helix, in the junction between the B and C surfaces (4) (Fig. 1). Using the software program VADAR (33), we found that the overall levels of exposure (fractions of the solvent-accessible surface area) for these two residues are 35 and 44%, respectively. G136 of MinCTm is probably not exposed since its overall level of exposure is only 2%. This residue is located in a turn in close proximity to the A surface, which was predicted to be the region of MinC dimerization (4) (Fig. 1). Residue G146 of MinCTm is located in the C surface in close proximity to the B-C surface junction, in the third turn of the ß-helix (4) (Fig. 1), and it is not surface exposed. In MinCTm, the homologue of the nonconserved residues P141 of MinCEc and E144 of MinCNg is the H116 residue, which is located within the C surface, in close proximity to the A-C surface junction (4) (Fig. 1). Our results show that MinCEc G161, which is located in proximity to the A surface, is required for proper protein self-interaction. In addition, analysis of the B factor for this glycine revealed that it is not flexible and is completely buried in the dimer interface. However, the other three conserved glycine residues, which are located within or near the B-C surface junction in the MinC C terminus and which have B factors indicating that they are relatively flexible, are not involved in MinC homodimerization but are essential for the MinC-MinD interaction.
CD reveals that MinCNg glycine mutants have an unchanged secondary structure. Glycine is a small residue that can adopt a wide range of backbone torsion angles and is often found in ß-turns (1). Since the completely conserved residues G111, G129, G136, and G146 of MinCTm are found within or in close proximity to ß-turns (4), the structural properties of these residues may be important for the overall MinC structure. Therefore, the folded state of the MinCNg glycine mutants was evaluated by far-UV CD. Analysis of these proteins indicated that the secondary structure of the mutant proteins was essentially identical to that of the wild-type protein (Fig. 6). Although this assay did not demonstrate that the tertiary structure of the proteins is unchanged, significant structural perturbations are unlikely since each glycine substitution in MinC selectively affects its interaction with either MinC or MinD but not its interaction with both proteins.
|
| DISCUSSION |
|---|
|
|
|---|
To investigate whether the conserved glycine residues of MinC are essential for protein function due to their critical structural locations, each glycine was mapped on the C-terminal surfaces (A, B, and C) of the crystal structure of MinCTm. Our analysis revealed that MinCEc G135 and G154 and the corresponding residues MinCNg G138 and G157 are in the first and second turns, respectively, of the ß-helix, in the junction between the B and C surfaces. MinCEc G171 and the corresponding residue MinCNg G174 are located within the C surface near its junction with the B surface (4) (Fig. 1). Interestingly, our protein-protein interaction assays demonstrated that these glycine residues are involved in the interaction between MinC and MinD but not in MinC homodimerization. Therefore, the B-C surface junction of MinC is probably the region responsible for the interaction of MinC with MinD. By contrast, MinCEc G161 and the corresponding residue MinCNg G164 are located in a turn in close proximity to the A surface, the region of MinC dimerization (4) (Fig. 1). Yeast two-hybrid assays provided direct experimental evidence for the involvement of the A surface in MinC dimerization since the MinCEc G161S mutant was not able to self-interact. In addition, our results demonstrate that MinC dimerization is required for the protein function as a cell division inhibitor because the MinCEc G161 or MinCNg G164 mutant was also unable to inhibit cell division.
As determined by CD analyses, the mutated MinC proteins did not have gross structural changes in their secondary structures. In addition, the alteration of protein-protein interactions involving MinC was specific to certain glycine residues (i.e., interactions were lost with either MinC or MinD but not with both proteins simultaneously). Therefore, significant structural perturbations of the mutant proteins cannot explain their loss of function as cell division inhibitors. Another study, involving a mutation in rat insulin-like growth factor-binding protein 5, has also shown that replacement of a critical glycine with glutamine causes the protein to lose activity, although the mutation did not result in gross conformational changes in the protein (27).
It is still possible that local structural perturbations that are transparent to CD analysis but nevertheless affect protein-protein interactions are present in the MinC glycine mutants. Such structural changes include altered protein flexibility and/or stability or changes in the electrostatic nature of the mutant MinC proteins. Glycine, which is often present in ß-turns, may confer flexibility to a protein backbone due to its single hydrogen atom side chain (1). Although the four conserved glycines of MinC are located within or in close proximity to the C-terminal ß-helix turns, the B factors for the solved structure of MinCTm indicate that only G111, G129, and G146 (G138, G157, and G174 in MinCNg) are relatively flexible. Therefore, mutation of these residues may have resulted in reduced protein flexibility, thereby affecting the movement of the MinC C-terminal domain necessary for mediating interactions with MinD. By contrast, MinCTm G136 (G164 in MinCNg) is not flexible and remains buried in the homodimer interface. Alternatively, replacement of glycine with either aspartic acid (MinCEc G135D and G154D and MinCNg G138D and G157D) or glutamic acid (MinCEc G171E and MinCNg G174E) may have introduced electrostatic repulsion at the protein-protein interfaces.
Two mutant proteins, MinCEc G171E and MinCNg G174E, had decreased levels of expression compared to the levels of expression of wild-type proteins, suggesting that these proteins had decreased stability. Sen and Rothfield (26) have also shown that a G171S mutation of MinCEc led to protein instability. Therefore, low MinCEc G171E protein levels could explain why this protein exhibited decreased self-interaction compared to that of wild-type MinCEc and did not interact with MinDEc. Kong et al. (17) showed that a G145A substitution in the human glutathione transferase P1-1 resulted in loss of enzyme activity due to altered stability of the protein, despite crystallographic analyses which revealed that the structure of the mutant protein was identical to the structure of the wild-type protein.
In order to identify regions of MinD involved in its interaction with the C terminus of MinC, a MinC-MinD association was modeled by using the available structures of MinCTm (4) and MinDPf (8) (Fig. 7). The
-7 helix of MinD has been implicated previously in the interaction of this protein with MinC (8). We modeled MinDPf as a dimer and observed that part of the
-7 helix of each MinDPf monomer is exposed, suggesting that this region may be available for interaction with MinC. Our structural analysis showed that three hydrophobic amino acids of the
-7 helix of MinDPf (L148, M152, and I156) may remain surface exposed after formation of a MinDPf dimer. However, sequence alignments of MinD (8, 29) revealed that only L148 and I156 of MinDPf have homologous aliphatic amino acids at the same positions in other species. Most of the amino acids that align with L148 are valines (e.g., in the MinDNg and MinDEc sequences) or isoleucines. Similarly, the majority of MinD sequences, including the MinDNg and MinDEc sequences, have a glycine at the position that aligns with I156. We propose that the glycine residues corresponding to MinCTm G111 and G129, which are surface exposed and are located in the B-C surface junction of the C terminus, may participate in hydrophobic associations with the surface-exposed residues of the
-7 helix of MinD corresponding to MinDPf L148 and I156 (Fig. 7B and C). It has been reported previously that glycine residues can participate directly in protein-protein interactions (2, 6). Lutkenhaus and Sundaramoorthy (21) recently proposed that the interaction between MinC and MinD probably occurs in the cytoplasm and that the MinD-ATP-MinC complex persists because MinC does not stimulate the ATPase activity of MinD.
|
| ACKNOWLEDGMENTS |
|---|
We thank P. Fabre and H. Li for assisting with plasmid construction, as well N. Goto and N. Eng for their helpful suggestions regarding the manuscript.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||